OpGen, Inc.(OPGN)

Description: OpGen, Inc. operates as an early commercial stage company using molecular testing and bioinformatics to assist healthcare providers to combat multi-drug-resistant bacterial infections. It offers Acuitas multi-drug-resistant organisms (MDRO) gene test, a molecular screening tool that detects 10 critical MDRO genes from 1 patient swab. The company also provides Acuitas CR Elite Test, which adds the ability to procure a standard microbiological culture result that provides additional information about the identified MDRO gene and its antibiotic susceptibility profile. In addition, it develops Acuitas Lighthouse MDRO bioinformatics product, which focuses on providing MDRO molecular information about an individual patient's resistance profile. OpGen, Inc. has a strategic collaboration with Hitachi High-Technologies Corporation to commercialize its genome mapping technology for mapping, assembly, and analysis of human DNA. The company was incorporated in 2001 and is headquartered in Gaithersburg, Maryland.

---

Keywords: Antibiotics Healthcare Providers Organisms Bacteria Bioinformatics Veterinary Medicine Bacterial Infections Informatics Genome Antimicrobial Resistance Evolutionary Biology Multi Drug Resistant Bacterial Infections

---

Home Page: www.opgen.com

OPGN Technical Analysis

9717 Key West Avenue
Rockville, MD 20850
United States
Phone: 240 813 1260

---

Officers

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)